This is not the first time pharmaceutical companies have tried to sidestep traditional distribution models
Provided youre handling the treatment well, your healthcare provider may recommend raising the dose to 1.0 mg following an additional four-week period Continuing Therapy and Maintenance Dosing For many individuals, a maintenance semaglutide dosage of 1.0 mg once a week is sufficient
Semaglutide has the longer cardiovascular track record Semaglutide's cardiovascular benefit is backed by dedicated outcomes trials SUSTAIN-6, PIONEER-6, and the large SELECT trial that have already reported results
TRIUMPH-4 answered that in April 2026
Is the FDA required to follow the PCAC's recommendation
Retatrutide targets GLP-1, GIP, and glucagon, expanding focus into energy expenditure, fat metabolism pathways, and advanced body composition research